Abstract
Kostnad-effekt analyse av robotassistert kirurgi i hode-hals kirurgi (TORS) til behandling av orofarynxkreft. Sammenlignes mot primær radiokjemoterapi. Resultat: Sammenlignbar kost per QALY. Tendens til at den inkrementelle kost/effekt ratioen er bedre for robotkirurgi. Bedre effekt og lavere kostnad.
A cost-effectiveness analysis of the implementation of trans oral robotic surgery (TORS) in the treatment of oropharyngeal carcinoma. Comparison with todays standard treatment which is radiochemotherapa (CRT). Results: Cost per QALY is reasonably similar to todays treatment. Tendency for positive incremental ratio. Lower total cost and improved over all effect.